Landscape of germline mutations in 1144 patients (Pts) with gastrointestinal (GI) cancers.

被引:0
|
作者
Salem, Mohamed E.
Amacker-North, Lisa
Gleason, Mariah
Athens, Aly
Worrilow, William Mills
McNeely, Lindsay
Broyhill, Katherine
Puccini, Alberto
Kim, Edward S.
Elrefai, Sara
机构
[1] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[3] Levine Canc Inst, Charlotte, NC USA
[4] USC Keck Sch Med, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13660
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Histopathologic Characterization of Breast Cancers in Patients with Non-BRCA Germline Mutations
    Meiss, Alice
    Thomas, Martha H.
    Higgs, Lydia
    Atkins, Kristen
    Mills, Anne
    LABORATORY INVESTIGATION, 2018, 98 : 91 - 91
  • [42] Germline PARP4 mutations in patients with primary thyroid and breast cancers
    Ikeda, Yuji
    Kiyotani, Kazuma
    Yew, Poh Yin
    Kato, Taigo
    Tamura, Kenji
    Yap, Kai Lee
    Mester, Jessica L.
    Nielsen, Sarah H.
    Raymon, Grogan H.
    Eng, Charis
    Nakamura, Yusuke
    CANCER RESEARCH, 2016, 76
  • [43] Histopathologic Characterization of Breast Cancers in Patients with Non-BRCA Germline Mutations
    Meiss, Alice
    Thomas, Martha H.
    Higgs, Lydia
    Atkins, Kristen
    Mills, Anne
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [44] Immune response to SARS-CoV-2 vaccine in patients (pts) with gastrointestinal (GI) cancers receiving systemic treatment in Immunocovid-19 study
    Caputo, F.
    Rotolo, M.
    Carretto, E.
    Albertazzi, L.
    Ciardiello, G.
    Cavuto, S.
    Savoldi, L.
    Lombardi, M.
    Soncini, S.
    Galimberti, C.
    Perrone, M.
    Masini, C.
    Bologna, A.
    Di Cicilia, R.
    Banzi, M.
    Pagano, M.
    Panebianco, M.
    Damato, A.
    Neri, A.
    Pinto, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S205 - S206
  • [45] State of the art of gastrointestinal (GI) cancer trials for older patients (pts): A systematic review (SR)
    Fazio, R.
    Audisio, A.
    Saad, E. D.
    Bregni, G.
    Sur, D.
    Dapra, V.
    Conti, C.
    Abbassi, F-Z
    Benhima, N.
    Assaf, I.
    Hendlisz, A.
    van Laethem, J-L
    Sclafani, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S201 - S202
  • [46] Landscape of Germline Mutations in Solid Tumor Patients with Antecedent or Subsequent Myeloid Neoplasms
    Hein, Kimberly
    Routbort, Mark
    Luthra, Rajyalakshmi
    Roy-Chowdhuri, Sinchita
    Bueso-Ramos, Carlos
    Yang, Richard
    Quesada, Andres
    Thakral, Beenu
    Patel, Keyur
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1152 - S1152
  • [47] FOrMAT: Feasibility of a molecular characterization approach to treatment of patients (pts) with advanced gastrointestinal (GI) tumors
    Moorcraft, Sing Yu
    de Castro, David Gonzalez
    Cunningham, David
    Walker, Brian A.
    Wilson, Sanna Hulkki
    Perez, Javier Diez
    Peckitt, Clare
    Wotherspoon, Andrew
    Begum, Ruwaida
    Valeri, Nicola
    Gerlinger, Marco
    Braconi, Chiara
    Rao, Sheela
    Watkins, David
    Chau, Ian
    Starling, Naureen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [48] Exceptional sustained responses to ipilimumab/nivolumab (ipi/nivo) in patients (pts) with advanced pancreaticobiliary cancers and germline DNA damage repair (DDR) mutations.
    Terrero, Gretel
    Datta, Jashodeep
    Pollack, Terri
    Naveda, Alissette
    Abushahin, Laith, I
    Sussman, Daniel A.
    Pimentel, Agustin
    Lockhart, Albert Craig
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Incidence and Prevention of Venous Thromboembolism (VTE) in Patients (pts) Undergoing Surgery for Gastrointestinal (GI) Malignancy
    Okano, M.
    Ikeda, M.
    Nakagawa, S.
    Haraguchi, N.
    Takemasa, T.
    Mizushima, T.
    Ishii, H.
    Yamamoto, H.
    Sekimoto, M.
    Doki, Y.
    Mori, M.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 84 - 84
  • [50] Improving clinician confidence and practice behavior on the therapeutic management of microsatellite-instability high (MSI-H) gastrointestinal (GI) cancers.
    Jaganathan, Hamsa
    Roc, Anne
    Turell, Wendy
    Broaddus, Russell
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)